CODOX-M/IVAC PROTOKOLÜ

Kaynaklar:

1- Mead GM, Sydes MR, Walewski J, et al. UKLG LY06 collaboratorsAn international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study., Ann Oncol, 2002, vol. 13 8(pg. 1264-1274)

2- G.M. Mead, S.L. Barrans, W. Qian, et al. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial) Blood, 112 (2008), pp. 2248-2260.